Centene Corporation
A U.S. managed-care company focused on Medicaid, Medicare, Affordable Care Act marketplace, behavioral-health, and other government-sponsored health programs.
Last updated August 27, 2026
Overview
Centene Corporation is a U.S.-based healthcare enterprise that administers and insures government-sponsored and privately insured health programs. Its principal role is as an intermediary between public programs, employers, healthcare providers, and members. The company operates managed-care plans for Medicaid beneficiaries, Medicare members, people purchasing coverage through Affordable Care Act marketplaces, and selected commercial insurance customers. Its services can include medical-plan administration, provider-network management, care coordination, pharmacy-related services, behavioral healthcare, specialty programs, and correctional healthcare. The company traces its origins to Managed Health Services, founded in Milwaukee, Wisconsin, in 1984 by Elizabeth Brinn. After Brinn's death, the nonprofit organization was sold to investors, with proceeds supporting the Betty Brinn Foundation. Michael Neidorff joined Centene as chief executive in 1996 and oversaw a period of substantial expansion. Centene became a publicly traded company in December 2001 and subsequently broadened its capabilities through acquisitions and the creation of specialized operating divisions. A major development was the acquisition of US Script in 2006, which expanded Centene's pharmacy-benefit-management capabilities. Those activities were later organized with other subsidiaries under the Envolve businesses. In 2011, Centene and MHM Services established Centurion, a correctional-healthcare joint venture; Centene acquired MHM Services in 2018 and thereby obtained full ownership of its interest in Centurion. Centene also expanded its health-plan footprint through the acquisition of Health Net, completed in 2016, and the purchase of Fidelis Care, a New York nonprofit insurer, announced in 2017. Its 2019 agreement to acquire WellCare significantly strengthened the company's Medicaid and Medicare presence, while the 2022 acquisition of Magellan Health added behavioral-health and specialty-care capabilities. Centene began participating in state Medicaid programs through Affordable Care Act exchanges in 2014. Its consumer-facing insurance brands have included Ambetter for marketplace coverage, WellCare and Allwell for Medicare offerings, and numerous state-specific Medicaid plans such as Sunshine Health, Peach State Health Plan, Superior HealthPlan, and Health Net. The company has also operated behavioral-health and specialty businesses associated with Magellan Health, as well as correctional-healthcare services through Centurion. Centene briefly developed a substantial United Kingdom healthcare presence. It acquired interests in Circle Health and obtained full control in 2021, while its subsidiary Operose Health acquired the AT Medics general-practice group and operated NHS primary-care practices. Centene sold Circle Health to PureHealth in 2023. In the United States, it sold Magellan Rx and PANTHERx Rare in 2022, reducing its exposure to pharmacy-benefit-management businesses. Centene's business has attracted regulatory and litigation scrutiny concerning network adequacy, claims administration, Medicaid pharmacy arrangements, government-program billing, and the integration of acquired businesses. Settlements with federal and state authorities have included payments relating to alleged duplicated or inflated claims, Medicaid pharmacy overpayments, and undisclosed discounts. These matters illustrate the compliance and public-policy risks inherent in administering publicly funded healthcare programs. Centene remains an active publicly traded healthcare company whose positioning centers on scale, government-program expertise, state-specific plan operations, and management of complex member populations.
History
Centene began in 1984 as Managed Health Services, a Milwaukee nonprofit founded by Elizabeth Brinn. After Brinn died, the organization was sold to investors, and the proceeds were directed to the Betty Brinn Foundation. The transaction left the foundation as an important shareholder in the company that developed into Centene. Michael Neidorff became chief executive in 1996. Under his leadership, Centene moved from a relatively focused Medicaid organization toward a diversified managed-care enterprise. The company went public in December 2001, giving it access to capital for expansion. Its 2006 acquisition of US Script added pharmacy-benefit-management expertise; those operations were later combined with other businesses into the Envolve divisions. Centene expanded beyond conventional health-plan administration in 2011 by forming Centurion with MHM Services to provide healthcare in correctional settings. Centene acquired MHM Services in 2018, strengthening its control over Centurion. The company also entered Affordable Care Act marketplace coverage in 2014, building the Ambetter brand and extending its role beyond state Medicaid contracts. Acquisitions became a central part of the company's growth strategy. Centene announced the purchase of Health Net in 2015 and completed it in 2016. In 2017 it agreed to acquire Fidelis Care, expanding its New York presence. The 2019 WellCare transaction further increased the company's scale in Medicaid and Medicare. In 2021 Centene agreed to acquire Magellan Health, completing the transaction in January 2022 and adding behavioral-health and specialty-care capabilities. The company also pursued healthcare operations outside the United States. Beginning in 2017, it acquired interests in United Kingdom healthcare services. Through MH Services, Centene purchased a 40 percent interest in Circle Health in 2019 and obtained full control in 2021. Its UK subsidiary Operose Health also acquired AT Medics and became a major provider of general-practice services to NHS patients. Centene sold Circle Health to PureHealth in August 2023, marking a retreat from that hospital-focused international activity. Centene subsequently simplified parts of its portfolio. In May 2022 it sold Magellan Rx and PANTHERx Rare for a combined reported consideration of $2.8 billion, reducing its direct exposure to pharmacy-benefit businesses. Governance also changed during this period: investor Politan Capital Management disclosed a substantial stake in late 2021, Neidorff announced plans to retire, and he stepped down in March 2022. Sarah London succeeded him as chief executive. Centene's history has been accompanied by disputes over healthcare access, provider networks, claims, pharmacy-benefit arrangements, and public-program billing. Allegations involving a Texas Medicaid member's cancer surgery, Ambetter provider access, the Health Net acquisition, federal veterans' claims, and state Medicaid pharmacy payments generated litigation, regulatory attention, or settlements. The company's development therefore reflects both the expansion of government-sponsored managed care and the compliance challenges of operating at the intersection of insurers, public agencies, providers, and patients.
- 2023Circle Health is sold
Centene sells Circle Health to PureHealth.
- 2022Magellan Health acquisition closes
Centene completes its acquisition of Magellan Health.
- 2021Centene obtains full control of Circle Health
The company takes full control of its UK private-hospital business.
- 2018MHM Services acquisition
Centene acquires MHM Services and its interest in Centurion.
- 2016Health Net acquisition closes
Centene completes its acquisition of Health Net.
- 2014Marketplace expansion
Centene begins offering state Medicaid programs through Affordable Care Act exchanges.
- 2011Centurion is formed
Centene and MHM Services establish Centurion as a correctional-healthcare joint venture.
- 2006US Script acquisition
The acquisition expands Centene's pharmacy-benefit-management capabilities.
- 2001Centene goes public
Centene completes its initial public offering in December.
- 1996Michael Neidorff becomes chief executive
Michael Neidorff joins the company as CEO and later leads its expansion into a broad managed-care enterprise.
- 1984Managed Health Services is founded
Elizabeth Brinn establishes Managed Health Services in Milwaukee, Wisconsin, providing the organizational foundation for Centene.
Products and positioning
A large managed-care organization specializing in government-sponsored healthcare, state-specific Medicaid administration, Medicare coverage, marketplace insurance, and services for complex or underserved populations.
Medicaid managed careGovernment-sponsored health insurance1984
Centene's core business is the administration of state Medicaid programs through geographically focused health-plan brands. These plans coordinate medical care, maintain provider networks, manage utilization, and support members who qualify for publicly funded coverage. State brands include Sunshine Health, Peach State Health Plan, Superior HealthPlan, Buckeye Health Plan, and numerous others.
AmbetterACA marketplace insurance2014
Ambetter is Centene's principal Affordable Care Act marketplace insurance platform. It offers individual and family health plans through state and federal exchanges, with plan designs, networks, and availability varying by jurisdiction.
WellCare and AllwellMedicare and managed-care plans
WellCare and Allwell represent Centene's Medicare-oriented offerings, including Medicare Advantage and related products. WellCare also appears in state Medicaid operations, reflecting Centene's practice of using established brands across government-sponsored segments.
Magellan Health servicesBehavioral and specialty healthcare2022
Magellan Health added behavioral-health, specialty-care, and related management capabilities to Centene's portfolio. The business complemented Centene's insurance operations by addressing complex behavioral and specialty populations.
CenturionCorrectional healthcare2011
Centurion provides healthcare services in correctional settings. It originated as a joint venture between Centene and MHM Services and became more closely controlled by Centene after the 2018 MHM Services acquisition.
Commercial health insuranceCommercial insurance
Centene has also operated selected commercial insurance businesses, including products associated with Health Net and QualChoice. These offerings supplement its much larger government-sponsored healthcare portfolio.
Flagship businesses
- Ambetter marketplace health plans
- WellCare Medicare and Medicaid plans
- State Medicaid plans
- Magellan behavioral-health services
- Centurion correctional healthcare
Brand decisions
- 2023Sale of Circle HealthM&A
Centene had developed a UK healthcare presence through Circle Health but later chose to exit that business.
What changed. Centene sold Circle Health to PureHealth.
Aftermath. The transaction reduced Centene's international hospital-services exposure.
- 2022Sale of pharmacy-benefit businessesStrategy
Centene reviewed its portfolio after adding Magellan Health and sought to reduce exposure to pharmacy-benefit operations.
What changed. The company sold Magellan Rx and PANTHERx Rare.
Aftermath. The divestitures simplified the portfolio and reduced Centene's direct pharmacy-benefit activities.
Combined reported sale value. $2.8 billion (May 2022)
- 2021Agreement to acquire Magellan HealthM&A
Centene wanted to strengthen behavioral-health and specialty-care capabilities.
What changed. Centene agreed to acquire Magellan Health.
Aftermath. The acquisition closed in January 2022 and expanded Centene's behavioral-health platform.
Announced transaction value. $2.2 billion (2021 announcement)
- 2019Agreement to acquire WellCareM&A
Centene sought to increase scale in Medicaid, Medicare, and related government-sponsored healthcare markets.
What changed. The company announced a planned acquisition of WellCare.
Aftermath. The transaction expanded Centene's government-program portfolio and national operating footprint.
Announced transaction value. $17.3 billion (2019 announcement)
Leadership
| Name | Title | Tenure |
|---|---|---|
| Michael Neidorff | Chief Executive Officerformer | 1996–2022 |
| Sarah London | Chief Executive Officer | 2022– |
Controversies
- 2022Operose Health patient-safety criticismControversy
Centene's UK subsidiary Operose Health faced criticism over staffing levels, use of physician associates, and backlogs involving test results and hospital correspondence. Operose stated that most of its practices received good or outstanding regulatory ratings.
- 2021Health Net Federal Services claims allegationsControversy
Health Net Federal Services agreed to pay $97 million to resolve allegations concerning duplicated or inflated claims submitted to the Department of Veterans Affairs.
- 2021State Medicaid pharmacy settlementsControversy
Centene and its Envolve pharmacy-benefit operations reached settlements with several states concerning alleged overpayments and related practices in Medicaid pharmacy programs.
- 2018Ambetter network-access class actionControversy
A class action alleged that Ambetter enrollees were misled about plan benefits and had difficulty locating providers willing to accept their coverage.
- 2018Health Net acquisition litigationControversy
Two pension funds sued Centene, alleging that the Health Net acquisition caused corporate harm and that liabilities and investigations associated with Health Net had not been adequately disclosed.
- 2014Dispute over Texas Medicaid cancer surgery coverageControversy
Superior HealthPlan, a Centene-related Texas Medicaid plan, was reported to have denied coverage for an infant's brain-cancer surgery at Texas Children's Hospital. After public reporting, the decision was reversed and the surgery was covered.
Recent events
- 2022Centene completes Magellan Health acquisition
The acquisition of Magellan Health was completed.
M&A - 2022Centene sells pharmacy-benefit businesses
Centene sold Magellan Rx and PANTHERx Rare, exiting significant parts of its pharmacy-benefit-management portfolio.
M&A - 2021Centene agrees to acquire Magellan Health
Centene announced a transaction for Magellan Health, broadening its behavioral-health and specialty-care capabilities.
M&A - 2019Centene announces WellCare acquisition
Centene announced plans to acquire WellCare in a transaction intended to strengthen its Medicaid and Medicare businesses.
M&A - 2017Centene announces acquisition of Fidelis Care
The company announced an agreement to acquire Fidelis Care, a nonprofit insurer serving New York.
M&A - 2016Centene completes acquisition of Health Net
Centene finalized its acquisition of Health Net, expanding its managed-care operations and geographic reach.
M&A
Sources
Cite this profile: Cite the canonical profile. /brand-wiki/centene-corporation · Editorial policy · How profiles are compiled